ESPR vs. GREK

Last updated Aug 1, 2026

ESPR (Esperion Therapeutics, Inc.) is a stock, while GREK (Global X MSCI Greece ETF) is Emerging Markets Equities fund tracking the MSCI All Greece Select 25/50 Index. Over the past 10 years, ESPR returned -11.79%/yr vs 17.36%/yr for GREK. Their 0.16 correlation means their historical movements had little consistent relationship.

Performance

ESPR vs. GREK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Esperion Therapeutics, Inc. (ESPR) and Global X MSCI Greece ETF (GREK). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ESPR achieves a -14.05% return, which is significantly lower than GREK's 22.60% return. Over the past 10 years, ESPR has underperformed GREK with an annualized return of -11.79%, while GREK has yielded a comparatively higher 17.36% annualized return.

ESPR

• 1D: 0.00%
• 1M: 0.63%
• 6M: -6.19%
• YTD: -14.05%
• 1Y: 127.14%
• 3Y*: 30.22%
• 5Y*: -29.19%
• 10Y*: -11.79%
• ALL TIME*: -12.06%

GREK

• 1D: -0.62%
• 1M: 5.48%
• 6M: 9.57%
• YTD: 22.60%
• 1Y: 36.74%
• 3Y*: 32.40%
• 5Y*: 27.82%
• 10Y*: 17.36%
• ALL TIME*: 6.26%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
GREK Global X MSCI Greece ETF	$9.46M	$9.35M	$7.83M

ESPR vs. GREK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ESPR Esperion Therapeutics, Inc.	-14.05%	68.18%	-26.42%	-52.01%	24.60%	-80.77%	-56.40%	29.63%	-30.13%	425.88%
GREK Global X MSCI Greece ETF	22.60%	76.11%	9.53%	42.72%	3.64%	6.14%	-13.89%	50.20%	-31.25%	34.80%

Correlation

The correlation between ESPR and GREK is 0.19, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.19
Correlation (3Y) Balances recent behavior with more history.	0.15
Correlation (5Y) Shows whether the relationship held over a longer period.	0.14
Correlation (10Y) Provides a long-term view across more market conditions.	0.17
Correlation (All Time) Calculated using the full available price history since Jun 26, 2013	0.16

Return for Risk

ESPR vs. GREK — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ESPR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

GREK

GREK Risk / Return Rank: 58
GREK Sharpe Ratio Rank: 65
GREK Sortino Ratio Rank: 69
GREK Omega Ratio Rank: 62
GREK Calmar Ratio Rank: 48
GREK Martin Ratio Rank: 46

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ESPR vs. GREK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Esperion Therapeutics, Inc. (ESPR) and Global X MSCI Greece ETF (GREK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ESPR	GREK	Difference
Sharpe ratio: Return per unit of total volatility	1.87	1.48	+0.38
Sortino ratio: Return per unit of downside risk	2.95	2.24	+0.71
Omega ratio: Gain probability vs. loss probability	1.39	1.27	+0.12
Calmar ratio: Return relative to maximum drawdown	3.16	1.71	+1.45
Martin ratio: Return relative to average drawdown	7.64	5.27	+2.37

ESPR vs. GREK - Sharpe Ratio Comparison

The current ESPR Sharpe Ratio is 1.87, which is comparable to the GREK Sharpe Ratio of 1.48. The chart below compares the historical Sharpe Ratios of ESPR and GREK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ESPR vs. GREK - Drawdown Comparison

The maximum ESPR drawdown since its inception was -99.37%, which is greater than GREK's maximum drawdown of -79.50%. Use the drawdown chart below to compare losses from any high point for ESPR and GREK.

Drawdown Indicators

	ESPR	GREK	Difference
Max Drawdown Largest peak-to-trough decline	-99.37%	-79.50%	-19.87%
Max Drawdown (1Y) Largest decline over 1 year	-53.19%	-21.32%	-31.87%
Max Drawdown (3Y) Largest decline over 3 years	-80.94%	-21.32%	-59.62%
Max Drawdown (5Y) Largest decline over 5 years	-95.13%	-30.46%	-64.67%
Max Drawdown (10Y) Largest decline over 10 years	-99.10%	-57.04%	-42.06%
Current Drawdown Current decline from peak	-97.24%	-0.62%	-96.62%
Average Drawdown Average peak-to-trough decline	-70.15%	-44.86%	-25.29%
Ulcer Index Depth and duration of drawdowns from previous peaks	21.98%	6.92%	+15.06%

Volatility

ESPR vs. GREK - Volatility Comparison

The current volatility for Esperion Therapeutics, Inc. (ESPR) is 1.75%, while Global X MSCI Greece ETF (GREK) has a volatility of 7.63%. This indicates that ESPR experiences smaller price fluctuations and is considered to be less risky than GREK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ESPR	GREK	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.75%	7.63%	-5.88%
Volatility (6M) Calculated over the trailing 6-month period	59.70%	21.24%	+38.46%
Volatility (1Y) Calculated over the trailing 1-year period	90.39%	24.67%	+65.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	91.65%	24.49%	+67.16%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	83.40%	28.85%	+54.55%

Dividends

ESPR vs. GREK - Dividend Comparison

ESPR has not paid dividends to shareholders, while GREK's dividend yield for the trailing twelve months is around 2.43%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ESPR Esperion Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
GREK Global X MSCI Greece ETF	2.43%	3.46%	4.63%	2.61%	2.82%	2.16%	2.62%	2.25%	2.41%	2.13%	1.95%	1.52%

Frequently Asked Questions

Can I hold both ESPR and GREK in my portfolio?

ESPR and GREK have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ESPR or GREK?

GREK has higher volatility (7.63%) compared to ESPR (1.75%). In terms of maximum drawdown, ESPR dropped -99.37% vs GREK's -79.50%.

Which has better risk-adjusted returns?

ESPR currently has the higher Sharpe Ratio (1.87 vs 1.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.